New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.

Daniela TerraccianoEvelina La CivitaAlcibiade AthanasiouAntonietta LiottiMariano FiorenzaMichele CennamoFelice CrocettoPierre TennstedtRalph SchiessAlexander HaeseMatteo FerroThomas Steuber

Published in: The Prostate (2022)

Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic performance of the individual tests.

Keyphrases

prostate cancer
radical prostatectomy
public health
healthcare
mental health
health information
risk assessment
health promotion